Ota Financial Group L.P. Navidea Biopharmaceuticals, Inc. Transaction History

Ota Financial Group L.P.

  • $143 Million
  • Q2 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 28, 2020
SELL
$2.69 - $4.95 $176,464 - $324,720
-65,600 Closed
0 $0
Q2 2020

Jul 16, 2020
BUY
$0.7 - $4.16 $45,920 - $272,896
65,600 New
65,600 $258,000

Others Institutions Holding NAVB

# of Institutions
3
Shares Held
10.4K
Call Options Held
0
Put Options Held
0
View Full List

About NAVIDEA BIOPHARMACEUTICALS, INC.

NAVB Quotes by TradingView
  • Ticker NAVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,150,900
  • Description
  • Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...
More about NAVB
Track This Portfolio

Track Ota Financial Group L.P. Portfolio

Follow Ota Financial Group L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ota Financial Group L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ota Financial Group L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email